Presence of c.3956delC mutation in familial adenomatous polyposis patients from Brazil.

AIM To characterize APC gene mutations and correlate them with patient phenotypes in individuals diagnosed with familial adenomatous polyposis (FAP) in northern Brazil. METHODS A total of 15 individuals diagnosed with FAP from 5 different families from the north of Brazil were analyzed in this study. In addition to patients with histopathological diagnosis of FAP, family members who had not developed the disease were also tested in order to identify mutations and for possible genetic counseling. All analyzed patients or their guardians signed a consent form approved by the Research Ethics Committee of the João de Barros Barreto University Hospital (Belem, Brazil). DNA extracted from the peripheral blood of a member of each of the affected families was subjected to direct sequencing. The proband of each family was sequenced to identify germline mutations using the Ion Torrent platform. To validate the detected mutations, Sanger sequencing was also performed. The samples from all patients were also tested for the identification of mutations by real-time quantitative polymerase chain reaction using the amplification refractory mutation system. RESULTS Through interviews with relatives and a search of medical records, it was possible to construct genograms for three of the five families included in the study. All 15 patients from the five families with FAP exhibited mutations in the APC gene, and all mutations were detected in exon 15 of the APC gene. In addition to the patients with a histological diagnosis of FAP, family members without disease symptoms showed the mutation in the APC gene. In the present study, we detected two of the three most frequent germline mutations in the literature: the mutation at codon 1309 and the mutation at codon 1061. The presence of c.3956delC mutation was found in all families from this study, and suggests that this mutation was introduced in the population of the State of Pará through ancestor immigration (i.e., a de novo mutation that arose in one member belonging to this state from Brazil). CONCLUSION Regardless of its origin, the c.3956delC mutation is a strong candidate biomarker of this hereditary cancer syndrome in families of northern Brazil.

[1]  J. Ribeiro,et al.  APC germline mutations in families with familial adenomatous polyposis. , 2013, Oncology reports.

[2]  D. Carraro,et al.  Mutational spectrum of the APC and MUTYH genes and genotype–phenotype correlations in Brazilian FAP, AFAP, and MAP patients , 2013, Orphanet Journal of Rare Diseases.

[3]  D. Busam,et al.  Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis , 2012, Oncogene.

[4]  L. Michaud,et al.  Evaluation of Guidelines for Management of Familial Adenomatous Polyposis in a Multicenter Pediatric Cohort , 2011, Journal of pediatric gastroenterology and nutrition.

[5]  S. Rüdiger,et al.  Messing up disorder: how do missense mutations in the tumor suppressor protein APC lead to cancer? , 2011, Molecular Cancer.

[6]  W. Foulkes,et al.  A survey of APC mutations in Quebec , 2011, Familial Cancer.

[7]  C. Lázaro,et al.  Detection of genetic alterations in hereditary colorectal cancer screening. , 2010, Mutation research.

[8]  K. Nakao,et al.  Biallelic APC inactivation was responsible for functional adrenocortical adenoma in familial adenomatous polyposis with novel germline mutation of the APC gene: report of a case. , 2009, Japanese journal of clinical oncology.

[9]  S. Pena,et al.  DNA tests probe the genomic ancestry of Brazilians. , 2009, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[10]  J. Lubiński,et al.  Familial adenomatous polyposis of the colon , 2008, Hereditary cancer in clinical practice.

[11]  P. Møller,et al.  Guidelines for the clinical management of familial adenomatous polyposis (FAP) , 2008, Gut.

[12]  M. Nieuwenhuis,et al.  Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. , 2007, Critical reviews in oncology/hematology.

[13]  J. Štekrová,et al.  Molecular analysis of the APC and MYH genes in Czech families affected by FAP or multiple adenomas: 13 novel mutations , 2004, Human mutation.

[14]  I. Tomlinson,et al.  Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases , 2004, Gut.

[15]  G. Riegler,et al.  The mutation spectrum of the APC gene in FAP patients from southern Italy: Detection of known and four novel mutations , 2003, Human mutation.

[16]  I. Tomlinson,et al.  Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. , 2002, The American journal of pathology.

[17]  M. Krawczak,et al.  Different combinations of biallelic APC mutation confer different growth advantages in colorectal tumours. , 2002, Cancer research.

[18]  J Herman,et al.  Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  W F Bodmer,et al.  The ABC of APC. , 2001, Human molecular genetics.

[20]  K. Goss,et al.  Biology of the adenomatous polyposis coli tumor suppressor. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  R. Mariani-Costantini,et al.  APC gene mutations and colorectal adenomatosis in familial adenomatous polyposis , 2000, British Journal of Cancer.

[22]  S. Baylin,et al.  Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. , 1999, Cancer research.

[23]  M. Zago,et al.  Differential contribution of indigenous men and women to the formation of an urban population in the Amazon region as revealed by mtDNA and Y-DNA. , 1999, American journal of physical anthropology.

[24]  D. Morton,et al.  Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition , 1999, Journal of medical genetics.

[25]  J. Arends,et al.  APC mutations in human colorectal adenomas: analysis of the mutation cluster region with temperature gradient gel electrophoresis and clinicopathological features , 1998, The Journal of pathology.

[26]  Z. Cohen,et al.  Genotype-phenotype correlations in attenuated adenomatous polyposis coli. , 1998, American journal of human genetics.

[27]  P. Polakis.  The adenomatous polyposis coli (APC) tumor suppressor. , 1997, Biochimica et biophysica acta.

[28]  D. Eccles,et al.  Genotype-phenotype correlations of new causative APC gene mutations in patients with familial adenomatous polyposis. , 1995, Journal of medical genetics.

[29]  M. Fukayama,et al.  Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. , 1994, Cancer research.

[30]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[31]  K. Kinzler,et al.  Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C Summers,et al.  Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). , 1989, Nucleic acids research.

[33]  K. Goss,et al.  Exploiting APC function as a novel cancer therapy. , 2014, Current drug targets.

[34]  I. Blanco,et al.  [Familial adenomatous polyposis]. , 2006, Gastroenterologia y hepatologia.

[35]  C. Jordan.  Working with nature : resource management for sustainability , 1998 .